Phenserine Study

Examines the effects of a novel therapeutic (phenserine tartrate) in the treatment of Alzheimer’s disease.
Keck School of Medicine logo

More Details About the Study

Why should I participate in this study?

Study participants will help broaden our understanding of the potential therapeutic role of phenserine tartrate in degenerative cognitive impairment. They will also be compensated for their time.

Am I eligible to participate?

We are enrolling individuals who are:

  • 70-82 years old
  • Diagnosed with mild cognitive impairment OR Alzheimer’s disease
  • Must have study partner willing to participate as well

Share this study


More studies


The next phase of Alzheimer’s Disease Neuroimaging Initiative (ADNI) research, ADNI4 is now recruiting participants with or without memory issues to help us continue investigating important questions concerning early detection of mild cognitive impairment and Alzheimer’s Disease.

Read more »
Skip to content